KP

Kumari Priyanka

Active Director Director DIN 08025212
DIN 08025212 First appointment Jan 2018 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Kumari Priyanka

Data last updated:

Kumari Priyanka is a Director at Abrin Pharma Private Limited (since 2018). The company operates in Business Services. Abrin Pharma Private Limited reported revenue of ₹48.5 Lakh (FY 2025).

DIN 08025212
Primary Designation Director
Industry Business Services
First Appointment 19 Jan 2018
Oldest Company Age 8 yrs
Largest company Abrin Pharma Private Limited · ₹48.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abrin Pharma Private Limited U74999DL2018PTC328801
Director19 Jan 20182018₹48.5 Lakh (FY 2025)Active

Board colleagues of Kumari Priyanka

NameDINCompanyDesignation
Nilesh Kumar08025210Abrin Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Abrin Pharma Private Limited
Premium access

Shareholding and investment profile for Kumari Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Priyanka

Kumari Priyanka currently holds 1 directorship: Abrin Pharma Private Limited (Director, since 19 Jan 2018, revenue ₹48.5 Lakh (FY 2025)).

Kumari Priyanka was first appointed on 19 Jan 2018 as Director at Abrin Pharma Private Limited.

The current boards of Kumari Priyanka's companies include Nilesh Kumar (Abrin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available